373
Views
3
CrossRef citations to date
0
Altmetric
Articles

Sub classification and clinico-hematological correlation of 40 cases of acute erythroleukemia—can proerythroblast/myeloblast and proerythroblast/total erythroid cell ratios help subclassify?

, , , &
Pages 381-385 | Published online: 04 Sep 2013

References

  • Fourth International Workshop on chromosomes in Leukemia Correlation between morphology and karyotype. Cancer Genet Cytogenet 1982;11:275.
  • Bennet JM, Catovsky D, Daniel MT, et al. Proposals for a classification of the acute leukemias. French—American—British (FAB) Co-operative group. Br J Haematol 1976;33: 451–458.
  • Society for Hematopathology program Proposed World Health Organization classification of neoplastic diseases of hemato-poietic and lymphoid tissues. Am J Surg Pathol 1997;21: 114–121.
  • Mazzella FM, Kowal-Vern A, Shrit A, et al. Acute erythroleukemia: Evaluation of 48 cases with reference to classification, cell proliferation, cytogenetics and prognosis. Am J Chin Pathol 1998;110:590–598.
  • Cuneo A, van Orshoven A, Michaux JI,, et al. Morphological, immunologic and cytogenetic studies in erythroleukemia: Evidence for multilineage involvement and identification of two distinct cytogenetic-clinic pathological types. Br J Haematol 1990;75:346–354.
  • Ruvidic R, Pavlovic-Kentera V, Boskovic D, et al. Acute erythremic myelosis (DiGuglielmo) following atypical aplastic anemia. Leuk Res 1986;10:451–455.
  • Choi BR, Ahn MJ, Lee WS, et al. Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy. Rheumatol Int 2005;25:311–313.
  • Garand R, Duchayne E, Blanchard D, et al. Minimally differentiated erythroleukemia (AML M6 `variant'): A rare subset of AML distinct from AML M6. Groupe Francais d'Hematologie Cellulaire. Br J Haematol 1995;90:868–875.
  • Park S, Picard F, Dreyfus F, et al. Erythroleukemia: A need for a new definition. Leukemia 2002;16:1399–1401.
  • Park S, Picard F, Guesnu M, et al. Erythroleukemia and RAEB-t: A same disease? Leukemia 2004;18:888–890.
  • Davey FR, Abraham NJR, Brunetto VI,, et al. Morphological characterstics of erythroleukemia (acute myeloid leukemia; FAB-M6) a CALGB study. Am J Haematol 1995;49: 29–38.
  • Jogai S, Varma N, Garewal G, et al. Acute erythroleukemia (AML-M6)—a study of clinico-hematological, morphological and dysplastic features in 10 cases. Indian J Cancer 2001;38: 143–148.
  • Olapade OI, Thangavelu M, Larson RA, et al. Clinical, morphological and cytogenetic characterstics of 26 patients with acute erythroblastic leukemia. Blood 1992;80: 2873–2882.
  • Forni M, Meyer PR, Levy NB, et al. An immunohistochemical study of hemoglobin A, hemoglobin F, muramidase, and transferring in erythroid hyperplasia and neoplasia. Am J Chin Pathol 1983;80:145–151.
  • Dominigo-Claros A, Larriba Irishman M, et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica 2002;87: 148–153.
  • Park S, Picard F, Azgui Z, et al. Erythroleukemia: A comparison between the previous FAB approach and the WHO classification. Leuk Res 2002;26:423–429.
  • Kowal-Vern A, Mazzella FM, Cotelingam JD. Diagnosis and characterization of acute erythroleukemia subsets by deter-mining the percentages of myeloblasts and proerythroblasts in 69 cases. Am J Hematol 2000;65: 5–13.
  • Leone G, Mele L, Pulsoni A, et al. The incidence of secondary leukemias. Haematologica 1999;84:937–945.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.